Project Grant HT94252411054
Award Date
11/1/24
Completion Date
10/31/28
Dollars Obligated
$2.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
The Defense Health Agency has awarded a $893,000 Project Grant to the University of California, Los Angeles (UCLA) - Office of Research Administration to conduct research under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, effective August 15, 2023 through August 14, 2027, will support UCLA's efforts to investigate the EGFR signaling network in glioblastoma, an aggressive form of brain cancer. As the prime grantee, UCLA will leverage its research...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $2,351,564.00 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. This four-year grant, with a period of performance from August 15, 2023 to August 14, 2027, will support research targeting the EGFR signaling network in glioblastoma. As the prime grantee, UCLA will leverage its research facilities, faculty...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a $1,366,628 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the role of oxidative mitochondrial metabolism in resistance to androgen receptor inhibition from July 1, 2023 to June 30, 2026. As the prime awardee, UCLA will leverage its research facilities and faculty...
The University of California, Los Angeles (UCLA) was awarded a $964,477 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "TARGETING THE RAL G PROTEINS TO TREAT TRIPLE-NEGATIVE BREAST CANCER", will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. The 3-year award, effective July 1, 2025 through June 30, 2028, supports innovative...
The University of California, Los Angeles (UCLA) has been awarded a $626,081 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program, administered by the Defense Health Agency. The grant, titled "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance," will support advanced biomedical research to transform healthcare for military service members and the broader public. The research...
The University of California, Los Angeles (UCLA) was awarded a $1,557,266 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, effective from March 1, 2025 to February 28, 2029, will support research to elucidate the molecular pathways by which proinflammatory microbes induce the development of interstitial cystitis. As a prominent public research university and 1862 Land Grant College, UCLA will leverage...
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
The U.S. Defense Health Agency awarded a $1,161,428 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2025, supports the development of a "Fully Automated, Multimodal, and Multiplexed Ferrobotic System for Point-of-Care Pathogenic and Serological Tick-Borne Disease Diagnosis." This advanced biomedical research project aims to transform healthcare for military...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a four-year $596,016 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCLA's research into "ENVIRONMENTAL AND GUT-BRAIN AXIS DETERMINANTS OF COGNITIVE OUTCOMES IN PD" from September 1, 2023 through August 31, 2027. As the prime awardee, UCLA will leverage its research expertise and...